Video

Claris Bio's Novel HGF Therapeutics For Corneal Diseases

Source: Bioprocess Online

Claris Bio is working to revolutionize front-of-the-eye treatments for neurotrophic keratitis by partnering with Kringle Pharma and Catalent.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: